Top Markets
#1 Siren Siren +38.43%
#2 RedStone RedStone +23.87%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#4 Ocean Protocol Ocean Protocol +15.39%
#5 Cysic Cysic +14.92%
#6 Arowana Arowana +13.88%
#7 Verus Coin Verus Coin +13.51%
#8 Perle Perle +11.75%
#9 KUB Coin KUB Coin +11.63%
#10 Wiki Cat Wiki Cat +10.25%
Coin of the day
Siren Siren
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Endymed Ltd Endymed Ltd

Endymed Ltd

ENDY
Classement en actions #31814
Endymed Ltd is a medical technology company focused on the global design,... Endymed Ltd is a medical technology company focused on the global design, development, and sale of energy-driven aesthetic treatment systems, catering to both professional practitioners and individual consumers. Its product offerings include the versatile EndyMed PRO, a platform capable of multiple applications. Another key product, PURE 2.0, provides professional-grade skin tightening, body contouring, and functional skin resurfacing. Furthermore, the firm leverages its proprietary 3DEEP radiofrequency technology to deliver a wide array of solutions for cosmetic enhancements, such as diminishing wrinkles, tightening skin, sculpting the body, improving texture, reducing cellulite and overall circumference, treating acne and related scarring, lessening stretch marks, performing RF microneedling, and fractional resurfacing. Established in 2007, the company is headquartered in Freehold, New Jersey.
Prix de l'action
$0.90225185
Dernière synchronisation: 2025-02-16
Capitalisation boursière
$11.99M
Changement (1 jour)
0.48%
Changement (1 an)
0.00%
Pays
US
Échange Endymed Ltd (ENDY)

Catégorie

Healthcare
Revenus pour Endymed Ltd (ENDY)
Revenus en Sep 2024 TTM : $18.94M
Selon les derniers rapports financiers de Endymed Ltd, le chiffre d'affaires actuel de l'entreprise (TTM) est de $18.94M. En 2022, l'entreprise a réalisé un chiffre d'affaires de $21.33M une diminution par rapport à le chiffre d'affaires de l'année 2021, qui était de $21.78M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Endymed Ltd de 2013 à 2026
Revenus à la fin de chaque année
Année Revenus Changez
2026 (TTM) $18.94M -16.84%
2023 $22.78M 6.77%
2022 $21.33M -2.06%
2021 $21.78M 51.85%
2020 $14.35M -12.78%
2019 $16.45M -10.88%
2018 $18.45M 5.20%
2017 $17.54M 23.08%
2016 $14.25M 10.05%
2015 $12.95M 22.80%
2014 $10.55M 79.94%
2013 $5.86M 0.00%
Revenus d’entreprises similaires ou concurrentes
Entreprise Revenus Différence de revenus Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 245,821.98%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 136,293.39%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 187,219.85%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 110,737.78%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B 34,278.40%
US